NCT04924998招募中不适用
Clinical Study Protocol for the Treatment of Immunoglobulin Light Chain Amyloidosis Cardiomyopathy
Second Affiliated Hospital, School of Medicine, Zhejiang University1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2021年6月1日最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 400
- 试验地点
- 1
- 主要终点
- Primary Outcome
研究概览
简要总结
In this study, patients diagnosed with Al-CM were selected to observe the effect of treatment and conduct long-term follow-up.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients aged 18-90 years, regardless of gender, diagnosed with Al-CM at the Second Affiliated Hospital of Zhejiang University School of Medicine;
- •Patients have the ability to understand the test, can cooperate with investigators.
排除标准
- •Unable to understand or unwilling to fill in informed consent forms or follow visitors
研究组 & 干预措施
AL-CM
干预措施: current treatment of AL-CM (Drug)
结局指标
主要结局
Primary Outcome
时间窗: 10 year
incidences of MACE-4(cardiovascular death, myocardial infarction, stroke and hospitalized unstable angina)
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
Enrolling By Invitation
不适用
The Therapeutic Effect of Immunotherapy in Patients With Advanced Lung Squamous CarcinomaSquamous Cell Lung CancerNCT06647836Wuhan Union Hospital, China1,000
已完成
2 期
CMC-544 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL)Acute Lymphoblastic LeukemiaNCT01134575M.D. Anderson Cancer Center90
已完成
1 期
Use of ACA 125 in Patients With Ovarian Cancer: Safety and Immune ResponseFallopian Tube NeoplasmsPeritoneal NeoplasmsOvarian CancerNCT00103545AGO Study Group36
已完成
不适用
Feasibility of Immunotherapy Plus Chemotherapy Administration to Patients With Bronchial Cancer in a Hospital-at- Home SettingBronchial CancerNCT04802902Centre Hospitalier de PAU10
已完成
2 期
GM-CSF as Adjuvant Therapy of MelanomaMalignant MelanomaNCT00350597Northern California Melanoma Center50